Frequency of Fabry disease in a juvenile idiopathic arthritis cohort

Abstract

Background Fabry disease (FD) is a rare, X-linked, multisystemic lysosomal storage disorder (LSD) that results from a deficiency in the hydrolase alpha-galactosidase A (⍺-GalA). During childhood, classic FD symptomatology is rare. The majority of children may show non-specific symptoms, including in the musculoskeletal system. The prevalence of FD among juvenile idiopathic arthritis (JIA) patients is unknown. Objective This study aimed to identify the frequency of FD in a JIA cohort, characterizing early clinical symptoms, enzyme titers, and GLA genotyping. Methods Children with JIA followed in a tertiary Children Hospital cohort were selected. Clinical, laboratory and familiar information were recorded. Molecular genetic testing to detect GLA gene mutations was performed in girls and enzymatic analysis in boys. Results In 89 patients (56.2% female, age at disease onset: 8.93 ± 4.35 years), one male (1.12%) patient presented pathogenic mutation in GLA gene, c.1244 T > C p.L415P, one female patient had a variant of uncertain significance c.38C > T (p.Ala13Val). Three additional (3.4%) patients had the enzymatic activity of alpha-galactosidase slightly decreased. We observed the presence of intronic variants in 44.44% of patients in our cohort: c.1000-22C > T; c.370-81_-77del; c.640-16A > G; c.10C > T; c.548-125C > G and c.-12G > A. These variants and their combination were associated with clinical symptoms in our cohort. Conclusions The incidence of FD in our cohort was 1.12%. Intronic variants were associated with symptoms previously described in the literature. Screening for FD in JIA may be a reasonable strategy for those with an atypical pattern of pain.

A family case of fabry disease in the practice of a pediatric rheumatologist

“…При этом не происходит органического поражения и деструкции суставов, а данные изменения лишь имитируют системные проявления и являются ревматологическими «масками» болезни Фабри [19]. Особенно рекомендовано исключать болезнь Фабри у пациентов с юношеским артритом при явном отсутствии эффекта от проводимой терапии и сохранении болевого синдрома без лабораторных и инструментальных изменений, характерных при данном заболевании [20].…”

Multidisciplinary Management of Fabry Disease: Current Perspectives

“… 51 A recent study of our group observed a frequency of 1.12% of FD in a cohort of juvenile idiopathic arthritis (JIA) patients. 52 …”